Chlamydia trachomatis (Vaccines)

Vaccine May Protect Against Major Cause of Blindness

Published in Women's Health Weekly, October 28th, 1996

Scientists at The Johns Hopkins University in Maryland and the University of Massachusetts have developed a vaccine that may prevent or speed recovery from chlamydia, the world's leading cause of infectious blindness and sexually transmitted diseases.

The vaccine is the first to use successfully only a purified anti-chlamydial antibody in a vaccine to immunize against and stop this infectious disease.

In animal experiments supported by the National Institutes of Health, the Edna McConnell Clark Foundation, and Research to Prevent Blindness, the vaccine protected mice from eye infections with Chlamydia trachomatis.

"This is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-10-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry